Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Locations section updated: site listings were adjusted (Georgia, New York, North Carolina, Ohio, Texas, North Holland, South Holland) and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T17:09:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.2, replacing v3.3.1, indicating a minor site update with no changes to study content or the user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:44:24.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.1 has been added, replacing the previous v3.2.0 revision. This is an internal site version update and does not affect study details, content, or navigation.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:07.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:56:01.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The study record for NCT04887259 shows termination of the LAVA-051 trial. The note states this decision was a business decision and not due to safety concerns, and that the study did not progress to Phase 2.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:19.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and current status pointers; updated version to v3.2.0. - Removed the specific condition 'B-cell chronic lymphocytic leukemia' and the older version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:06:38.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.